scholarly journals Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

2017 ◽  
Vol 16 (4) ◽  
pp. 271-281 ◽  
Author(s):  
Tomas Kalincik ◽  
J William L Brown ◽  
Neil Robertson ◽  
Mark Willis ◽  
Neil Scolding ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Cohort Study ◽  
Interferon Beta ◽  
Treatment Effectiveness ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

Interferon-beta and disability progression in relapsing-remitting multiple sclerosis

2013 ◽  
Vol 115 ◽  
pp. S65-S69 ◽  
Author(s):  
Jelena Drulovic ◽  
Jelena Kostic ◽  
Sarlota Mesaros ◽  
Irena Dujmovic Basuroski ◽  
Nebojsa Stojsavljevic ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Beta ◽  
Disability Progression ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis

Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis

2013 ◽  
Vol 70 (2) ◽  
pp. 248 ◽  
Author(s):  
Benjamin M. Greenberg ◽  
Laura Balcer ◽  
Peter A. Calabresi ◽  
Bruce Cree ◽  
Anne Cross ◽  
...  
Keyword(s):  
Multiple Sclerosis ◽  
Interferon Beta ◽  
Disability Prevention ◽  
Relapsing Remitting ◽  
Remitting Multiple Sclerosis ◽  
Relapsing Remitting Multiple Sclerosis
Sign in / Sign up

Export Citation Format

Share Document